Net Cash Provided by (Used in) Financing Activities in USD of CAPRICOR THERAPEUTICS, INC. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Capricor Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Capricor Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $50.4K, a 97.8% decline year-over-year.
  • Capricor Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $153M, a 497% increase from 2023.
  • Capricor Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $25.6M, a 425% increase from 2022.
  • Capricor Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.87M, a 75.9% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $50.4K -$2.24M -97.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 $2.29M -$1.6M -41.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $3.9M +$3.87M +14082% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $27.5K -$12.6M -99.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $12.6M +$8.03M +177% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $4.55M +$3.12M +217% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $1.43M -$1.08M -43% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $2.51M +$2.51M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2013 $383K +$383K Jan 1, 2013 Mar 31, 2013 10-Q 2013-06-21
Q1 2012 $0 -$6.21K Jan 1, 2012 Mar 31, 2012 10-Q 2013-06-21
Q1 2011 $6.21K* Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-05-15

CAPRICOR THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $153M +$127M +497% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 $25.6M +$20.7M +425% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 $4.87M -$15.4M -75.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $20.2M -$13.2M -39.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $33.4M +$24.2M +264% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $9.18M +$2.32M +33.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $6.85M -$4.73M -40.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $11.6M -$7.05M -37.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $18.6M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-22
2012 $1.19M -$1.12M -48.4% Jan 1, 2012 Dec 31, 2012 10-K 2013-06-21
2011 $2.31M -$2.21M -48.9% Jan 1, 2011 Dec 31, 2011 10-K 2013-06-21
2010 $4.52M Jan 1, 2010 Dec 31, 2010 10-K 2012-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.